1. Home
  2. Stock quotes
  3. Sonnet BioTherapeutics Holdings
  4. Financial Ratios
  5. EV/EBITDA Ratio
Sonnet BioTherapeutics Holdings logo
Sonnet BioTherapeutics Holdings SONN
$ 2.91 -0.34%
mail-toReport an Error

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Sonnet BioTherapeutics Holdings EV/EBITDA Ratio 2011-2024 | SONN

Annual EV/EBITDA Ratio Sonnet BioTherapeutics Holdings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.833 -0.736 -0.822 -3.66 -4.38 -48.5 -2.58 -1.2 K -1.33 K -870 -1.18

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.833 -1.33 K -315